Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 246

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Advances in allergen-microarray technology for diagnosis and monitoring of allergy: The MeDALL allergen-chip

Open access
Lupinek, Christian, Wollmann, Eva, Baar, Alexandra, Banerjee, Srinita, Breiteneder, Heimo, Broecker, Barbara M., Bublin, Merima, Curin, Mirela, Flicker, Sabine, Garmatiuk, Tetiana, Hochwallner, Heidrun, Mittermann, Irene, Pahr, Sandra, Resch, Yvonne, Roux, Kenneth H., Srinivasan, Bharani, Stentzel, Sebastian, Vrtala, Susanne, Willison, LeAnna N., Wickman, Magnus, Lødrup-Carlsen, Karin C., Antó, Josep Maria, Bousquet, Jean, Bachert, Claus, Ebner, Daniel, Schlederer, Thomas, Harwanegg, Christian, Valenta, Rudolf·2014·Methods

Abstract

Allergy diagnosis based on purified allergen molecules provides detailed information regarding the individual sensitization profile of allergic patients, allows monitoring of the development of allergic disease and of the effect of therapies on the immune response to individual allergen molecules. Allergen microarrays contain a large variety of allergen molecules and thus allow the simultaneous detection of allergic patients’ antibody reactivity profiles towards each of the allergen molecules with only minute amounts of serum. In this article we summarize recent progress in the field of allergen microarray technology and introduce the MeDALL allergen-chip which has been developed for the specific and sensitive monitoring of IgE and IgG reactivity profiles towards more than 170 allergen molecules in sera collected in European birth cohorts. MeDALL is a European research program in which allergen microarray technology is used for the monitoring of the development of allergic disease in childhood, to draw a geographic map of the recognition of clinically relevant allergens in different populations and to establish reactivity profiles which are associated with and predict certain disease manifestations. We describe technical advances of the MeDALL allergen-chip regarding specificity, sensitivity and its ability to deliver test results which are close to in vivo reactivity. In addition, the usefulness and numerous advantages of allergen microarrays for allergy research, refined allergy diagnosis, monitoring of disease, of the effects of therapies, for improving the prescription of specific immunotherapy and for prevention are discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ymeth.2013.10.008

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 246

Metadata

Authors
Lupinek, C., Wollmann, E., Baar, A., Banerjee, S., Breiteneder, H., Broecker, B. M., Bublin, M., Curin, M., Flicker, S., Garmatiuk, T., Hochwallner, H., Mittermann, I., Pahr, S., Resch, Y., Roux, K. H., Srinivasan, B., Stentzel, S., Vrtala, S., Willison, L. N., Wickman, M., Lødrup-Carlsen, K. C., Antó, J. M., Bousquet, J., Bachert, C., Ebner, D., Schlederer, T., Harwanegg, C., & Valenta, R.
Venue
Methods
Publisher
Elsevier BV
Published
2014-03
Volume
66
Issue
1
Pages
106-119
ISSN
1046-2023 (ISSN-L)
OpenAlex
W2041278327
Cited by
246
References
2
FWCI
20.04
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Advances in allergen-microarray technology for diagnosis and monitoring of allergy: The MeDALL allergen-chip. https://app.cochat.ai/papers/10.1016/j.ymeth.2013.10.008
The paper
Lupinek, C., Wollmann, E., Baar, A., Banerjee, S., Breiteneder, H., Broecker, B. M., Bublin, M., Curin, M., Flicker, S., Garmatiuk, T., Hochwallner, H., Mittermann, I., Pahr, S., Resch, Y., Roux, K. H., Srinivasan, B., Stentzel, S., Vrtala, S., Willison, L. N., . . . Valenta, R. (2014). Advances in allergen-microarray technology for diagnosis and monitoring of allergy: The MeDALL allergen-chip. Methods. https://doi.org/10.1016/j.ymeth.2013.10.008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.